Clinical trial NCT03772639: Shared Decision Making in Hospitalized AECOPD
Official title: Shared Decision Making and Patient Engagement Program During AECOPD Hospitalization
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: COPD Exacerbation
Lead sponsor: Universidad de Granada
Sponsor class: OTHER
First posted: 2018-12-11
Enrollment: 42
Sex: ALL
Minimum age (years): 18
Maximum age (years): 100
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Patients require good communication with the physician to improve control illness. Shared decision making is a promising opportunity for chronic disease management due to the relative cost, medicine optimization and decreases hospital admissions/re-admissions

Detailed description: Chronic obstructive pulmonary disease (COPD) is the leading one on hospital care cost, physician services, and prescription drugs. Additionally to the disease progression with the reduction in lung function, COPD patients experiment a progressive decline in functional capacity and health-related quality of life (HRQoL) with a significant burden in terms of disability. Shared Decision Making is defined as an approach where clinicians and patients share the available information to making clinical decisions, and where patients are counseled. SDM is a way to empower patients when decisions are made about treatment as a determinant factor in patient-centered care. Decision aids have been proven effective in improving disease knowledge, decision making, and self-care.

Eligibility criteria: Inclusion Criteria:

* Inclusion criteria were COPD patients hospitalized due to acute exacerbation

Exclusion Criteria:

* Exclusion criteria were the inability to provide informed consent, the presence of psychiatric or cognitive disorders, progressive neurological disorders, organ failure, cancer, or inability to cooperate. Patients who had experienced another exacerbation of COPD in the previous month were also excluded.

Primary outcomes:
measure: Health related quality of life
timeFrame: Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up
Secondary outcomes:
measure: COPD Knowledge
timeFrame: Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up
measure: Adherence of inhalers
timeFrame: Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up
measure: Functional capacity
timeFrame: Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up
measure: Physical activity
timeFrame: Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up
measure: Nutritional status
timeFrame: Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up
measure: Functional capacity associated with breathlessness
timeFrame: Participants will be followed for the duration of hospital stay, an expected average of 9 days and after discharge 3 months follow up
Other outcomes:
Locations:
Study officials:
References:
citation: Cross AJ, Thomas D, Liang J, Abramson MJ, George J, Zairina E. Educational interventions for health professionals managing chronic obstructive pulmonary disease in primary care. Cochrane Database Syst Rev. 2022 May 6;5(5):CD012652. doi: 10.1002/14651858.CD012652.pub2.